Table IV.
Distribution of patients who died during the 30-day follow-up period after OOH contact with respect to age, exacerbation, or new health problem, and gender.1
| Heart disease (n = 357) |
Lung disease (n = 1395) |
Diabetes (n = 1331) |
Psychiatric disease (n = 320) |
Cancer (n = 1223) |
2 + diagosed (n = 2392) |
|||||||
| All deaths | 44 | (9.6) | 87 | (4.7) | 93 | (5.5) | 4 | (0.3) | 132 | (8.7) | 97 | (9.0) |
| Age groups: | ||||||||||||
| < 60 years | 0 | (0) | 6 | (7.8) | 4 | (5.9) | 1 | (25.0) | 11 | (16.0) | 12 | (13.8) |
| 61–75 years | 10 | (10.2) | 24 | (19.3) | 25 | (15.5) | 3 | (75.0) | 49 | (28.3) | 38 | (21.0) |
| 75 + years | 34 | (89.8) | 57 | (72.9) | 64 | (78.5) | 0 | (0) | 72 | (55.7) | 90 | (65.2) |
| Exacerbation | 15 | (24.5) | 37 | (43.8) | 31 | (38.8) | 2 | (50.0) | 47 | (35.8) | 48 | (36.2) |
| New health problem | 29 | (75.5) | 50 | (56.2) | 62 | (61.2) | 2 | (50.0) | 85 | (64.2) | 92 | (63.8) |
| Gender: | ||||||||||||
| Men | 23 | (69.4) | 41 | (42.2) | 43 | (40.2) | 3 | (75.0) | 62 | (44.3) | 68 | (46.7) |
| Women | 21 | (30.6) | 46 | (57.8) | 50 | (59.8) | 1 | (25.0) | 70 | (55.7) | 72 | (53.3) |
Note: 1In numbers with corresponding contact distribution-related weighted percentage.